Stanley Lapidus - 20 Sep 2022 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Director
Signature
/s/ Stanley Lapidus
Issuer symbol
LUCD
Transactions as of
20 Sep 2022
Net transactions value
-$57,683
Form type
4
Filing time
22 Sep 2022, 11:46:51 UTC
Previous filing
23 Feb 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUCD Common stock Sale $29,014 -17,000 -10% $1.71 152,320 20 Sep 2022 Direct F1, F2
transaction LUCD Common stock Sale $28,669 -16,864 -11% $1.70 135,456 20 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
F2 Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.